Blood News and Research

RSS

New link between impaired brain energy metabolism and delirium discovered

Scientists from Trinity College Dublin have discovered a new link between impaired brain energy metabolism and delirium - a disorienting and distressing disorder particularly common in the elderly and one that is currently occurring in a large proportion of patients hospitalized with COVID-19.

14 Jul 2020

Scientists develop new method to determine sizes of immune complexes in blood serum

Researchers of Peter the Great St.Petersburg Polytechnic University in collaboration with colleagues from Tsinghua University (China) developed a new dynamic light scattering method to determine the sizes of circulating immune complexes in blood serum.

14 Jul 2020

Dual inhibitor therapy may be safer for CLL patients, Moffitt study shows

Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. One in four new leukemia cases are CLL.

14 Jul 2020

HLA-G gene connected to male-to-female ratio at birth, survival of fetuses, and preeclampsia

Preeclampsia is globally a leading cause of illness and deaths among mothers and their babies. This severe pregnancy disorder occurs in up to five percent of all pregnancies.

14 Jul 2020

UTHealth physicians investigate blood pressure drug's effect on improving COVID-19 outcomes

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston.

14 Jul 2020

Researchers identify new factor that regulates the size of scar following heart injury

When a person has a heart attack, the person's coronary artery is blocked, cutting off the flow of blood and oxygen to that portion of the person's heart.

14 Jul 2020

Researchers review scientific articles on the role of zinc in COVID-19 prevention

Researchers from Sechenov University in collaboration with colleagues from Germany, Greece and Russia reviewed scientific articles on the role of zinc in the prevention and treatment of viral infections and pneumonia, with projections on those caused by SARS-CoV-2. The results were published in the International Journal of Molecular Medicine.

14 Jul 2020

Current assays reflect non-neutralizing antibodies, finds study

Several serologic tests have been developed to help diagnose the presence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), either currently or in the past. However, all of them are not equally effective.

14 Jul 2020

People with accelerated biological age at increased risk of COVID-19 symptom severity and mortality

Now, a new study published on the preprint server medRxiv in July 2020 discusses the explanation in terms of the biological aging markers in patients with severe disease, rather than the chronological age.

13 Jul 2020

Severely injured donor lungs can be successfully recovered outside the body

Respiratory disease is the third leading cause of death worldwide, and lung transplantation is still the only cure for patients with end-stage lung disease.

13 Jul 2020

International research collaboration to investigate the role of immune system in health

An international research collaboration to pioneer the field of immuno-cardiology and investigate ways to harness the power of the immune system to improve recovery from heart attacks will be led at the Perelman School of Medicine at the University of Pennsylvania by Jonathan Epstein, MD, executive vice dean, chief scientific officer and the William Wikoff Smith Professor of Cardiovascular Research.

13 Jul 2020

Patients with high blood sugar at higher risk of COVID-19 complications

The COVID-19 causes severe disease in patients with underlying health conditions, such as diabetes, hypertension, severe lung disease, heart disease, and a weakened immune system.

13 Jul 2020

Scientists discover common molecular feature found in SARS-CoV-2 neutralizing antibodies

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

13 Jul 2020

Clots, COVID-19 and survival

The novel coronavirus, now known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that causes COVID-19 disease, was first reported in Wuhan, Hubei Province of China in late December 2019. Since then, it has infected a large population across the world with the current number of SARS-CoV-2 infections standing at over 13 million and COVID-19 disease having killed over 571,000 individuals.

13 Jul 2020

Serology distinguishes children with MIS-C associated with COVID-19

Researchers in the United States say that measuring antibody titers against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may help to distinguish between multisystem inflammatory syndrome in children (MIS-C) and other clinically similar syndromes.

13 Jul 2020

Fully automated chip can reliably determine blood type within minutes

The need to first zero in on a blood group can delay blood transfusions in emergency situations, and this in turn can prove fatal.

13 Jul 2020

Research shows cardiovascular benefits of meditating

Meditation was linked to lower cardiovascular risk in a data analysis by Veterans Affairs researchers and colleagues.

13 Jul 2020

Long-studied protein can be used as biomarker for traumatic brain injury

Scientists at the Walter Reed Army Institute for Research have recently demonstrated that cathepsin B, a well-studied protein important to brain development and function, can be used as biomarker, or indicator of severity, for traumatic brain injury.

13 Jul 2020

Stress hormone is a crucial component of diabetes management, shows study

A new study by researchers at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine documents a clear link between the stress hormone cortisol and higher blood sugar levels in people with type 2 diabetes.

13 Jul 2020

Researchers analyze the effects of beta-blockers on men and women with hypertension

Women taking beta-blockers for hypertension with no prior history of cardiovascular disease (CVD) have a nearly 5% higher risk for heart failure than men when they present to hospitals with acute coronary syndrome, according to new research published today in Hypertension, an American Heart Association journal.

13 Jul 2020

Blood News and Research

New link between impaired brain energy metabolism and delirium discovered

Scientists develop new method to determine sizes of immune complexes in blood serum

Dual inhibitor therapy may be safer for CLL patients, Moffitt study shows

HLA-G gene connected to male-to-female ratio at birth, survival of fetuses, and preeclampsia

UTHealth physicians investigate blood pressure drug's effect on improving COVID-19 outcomes

Researchers identify new factor that regulates the size of scar following heart injury

Researchers review scientific articles on the role of zinc in COVID-19 prevention

Current assays reflect non-neutralizing antibodies, finds study

People with accelerated biological age at increased risk of COVID-19 symptom severity and mortality

Severely injured donor lungs can be successfully recovered outside the body

International research collaboration to investigate the role of immune system in health

Patients with high blood sugar at higher risk of COVID-19 complications

Scientists discover common molecular feature found in SARS-CoV-2 neutralizing antibodies

Clots, COVID-19 and survival

Serology distinguishes children with MIS-C associated with COVID-19

Fully automated chip can reliably determine blood type within minutes

Research shows cardiovascular benefits of meditating

Long-studied protein can be used as biomarker for traumatic brain injury

Stress hormone is a crucial component of diabetes management, shows study

Researchers analyze the effects of beta-blockers on men and women with hypertension

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News